Imperial College London


Faculty of MedicineDepartment of Medicine

Professor of Haemostasis & Thrombosis



+44 (0)20 3313 2178m.laffan




Mrs Lisa Pape +44 (0)20 3313 1320




5S5bHammersmith HospitalHammersmith Campus





Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for  postgraduate education in haematology. 



Arachchillage DRJ, Kamani F, Deplano S, et al., 2017, Should we abandon the APTT for monitoring unfractionated heparin?, Thrombosis Research, Vol:157, ISSN:0049-3848, Pages:157-161

Arachchillage DRJ, Laffan M, 2017, Pathogenesis and management of antiphospholipid syndrome, British Journal of Haematology, Vol:178, ISSN:0007-1048, Pages:181-195

Arachchillage DRJ, Laffan M, 2017, Can Mean Platelet Volume Be Used as a Predictor of Vascular Disease? Problems and Pitfalls, Seminars in Thrombosis and Hemostasis, Vol:43, ISSN:0094-6176, Pages:599-608

Gill D, Del Greco M F, Walker AP, et al., 2017, The Effect of Iron Status on Risk of Coronary Artery Disease A Mendelian Randomization Study-Brief Report, Arteriosclerosis Thrombosis and Vascular Biology, Vol:37, ISSN:1079-5642, Pages:1788-+

Griffiths S, Woo C, Mansoubi V, et al., 2017, Thromboelastography (TEG (R)) demonstrates that tinzaparin 4500 international units has no detectable anticoagulant activity after caesarean section, International Journal of Obstetric Anesthesia, Vol:29, ISSN:0959-289X, Pages:50-56

More Publications